Cyclobenzaprine Hydrochloride
Product Images NDC 70934-005

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 70934-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70934 005 15 Master Bottle Label Approval Rev B 09 19

This is a medication called Cyclobenzaprine Hydrochloride Tablets, USP 10mg. It comes in a bottle of 15 tablets and the National Drug Code (NDC) is 70934-005-15.*

FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)

FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)

This is a list of common side effects experienced by patients taking Cyclobenzaprine HCI Tablets at both 5mg and 10mg doses. The data shows the percentage of patients in each group who experienced drowsiness, dry mouth, fatigue, and headache. It also includes a group who were given a placebo.*

FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)

This text provides a summary of clinical studies and surveillance program for Cyclobenzaprine HClI tablets in 10 mg strength. The text reports the frequency of common side effects observed in the studies, including drowsiness, dry mouth, and dizziness. However, the percentages appear to be incomplete or truncated, making it difficult to interpret the actual results.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.